BioCryst Pharmaceuticals Announces Third Quarter Results Date

Author: Owen Jenkins Updated: 10-20-2025 07:31 AM

BioCryst Pharmaceuticals to Announce Financial Outcomes

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) has made an important announcement regarding its upcoming financial results for the third quarter of 2025. The company will unveil the details on the significant date of November 3, 2025.

Conference Call and Update on Corporate Activities

The management team at BioCryst will be hosting an engaging conference call and webcast at 8:30 a.m. ET on that same day. This is a critical opportunity for stakeholders to gain insights into the company’s financial standing and strategic directions for the future.

How to Access the Call

To participate in the conference call, interested parties can dial 1-844-481-2942 for those calling domestically, and 1-412-317-1866 for international callers. For maximum convenience, a live webcast along with a replay will be accessible within the investors section of the company's official website.

About BioCryst Pharmaceuticals

BioCryst Pharmaceuticals is a pioneering biotechnology firm dedicated to enhancing the quality of life for individuals suffering from hereditary angioedema and other rare diseases. With a strong emphasis on structure-guided drug design, the company develops first-in-class and best-in-class therapeutics, particularly aimed at conditions that are arduous to treat. Notably, BioCryst has successfully marketed ORLADEYO (berotralstat), recognized as the first oral, once-daily plasma kallikrein inhibitor. The company is also in the process of advancing a robust pipeline of small-molecule and protein therapies.

Investment Relationships

For inquiries regarding investments, individuals can reach out through the contact email at investorrelations@biocryst.com. Media-related questions can be directed to media@biocryst.com.

Conclusion

As BioCryst Pharmaceuticals gears up for their third quarter 2025 financial report, stakeholders are encouraged to stay tuned for updates and insights. With their dedication to innovative therapies in rare diseases, the company's developments are highly anticipated within the investment community.

Frequently Asked Questions

When will BioCryst report its third-quarter financial results?

BioCryst will report its third-quarter financial results on November 3, 2025.

What time is the conference call scheduled for?

The conference call will take place at 8:30 a.m. ET.

How can investors participate in the call?

Investors can dial 1-844-481-2942 for domestic calls or 1-412-317-1866 for international calls to participate in the conference call.

What is BioCryst's focus in the biotechnology field?

BioCryst focuses on developing innovative treatments for rare diseases, particularly hereditary angioedema, through structure-guided drug design.

How can I contact BioCryst for investor relations?

For investor inquiries, you can contact BioCryst at investorrelations@biocryst.com.

About The Author

Hi there I'm 38-year-old author and financial consultant Owen Jenkins. Having worked in the financial sector for more than ten years, I am well-versed in the subtleties and complexity that mold our financial environment. Following a degree in finance, I worked in a number of financial institutions honing my abilities in market analysis, financial planning, and investment strategies.

My love is teaching others about investing and personal finance. My goal in writing many books and articles has been to demystify financial ideas and give readers the information they need to make wise financial decisions. I write with a direct, useful style that emphasizes doable suggestions for daily living.

Along with writing, I lead webinars and seminars where I impart knowledge on how to successfully negotiate the financial world. I also write for financial journals and show up as a guest expert on financial news programs a lot. Whether they are new to investing or want to improve their approach, my mission is to enable people to take charge of their financial futures.

Beyond work, I like to hike, play the guitar, and spend time with my family. I think that balance is crucial and want to encourage people to strike a balance between their financial aspirations and their hobbies. I want to help people succeed and achieve financial security through my work, so having a good influence.

Contact Owen Jenkins privately here. Or send an email with ATTN: Owen Jenkins as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.